268 related articles for article (PubMed ID: 11446323)
1. [Irinotecan plus fluorouracil and folinic acid in metastatic colorectal cancer].
Krieger G
Strahlenther Onkol; 2001 Jun; 177(6):316-8. PubMed ID: 11446323
[No Abstract] [Full Text] [Related]
2. A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.
Underhill C; Goldstein D; Gorbounova VA; Biakhov MY; Bazin IS; Granov DA; Hossain AM; Blatter J; Kaiser C; Ma D
Oncology; 2007; 73(1-2):9-20. PubMed ID: 18334829
[TBL] [Abstract][Full Text] [Related]
3. [Standard therapy of CPT-11 for colorectal cancer].
Saitoh S; Sakata Y
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1345-51. PubMed ID: 11681240
[TBL] [Abstract][Full Text] [Related]
4. [Capecitabine and irinotecan].
Gasperoni S
Suppl Tumori; 2004; 3(4):S107-8. PubMed ID: 15206231
[No Abstract] [Full Text] [Related]
5. Irinotecan may extend survival in people with metastatic colorectal cancer.
Oncology (Williston Park); 1998 Oct; 12(10):1512. PubMed ID: 9798204
[No Abstract] [Full Text] [Related]
6. [Irinotecan in combination for colon cancer].
Ducreux M; Gil-Delgado M; André T; Ychou M; de Gramond A; Khayat D
Bull Cancer; 1998 Dec; Spec No():43-6. PubMed ID: 9932084
[TBL] [Abstract][Full Text] [Related]
7. Moving beyond fluorouracil for colorectal cancer.
Mayer RJ
N Engl J Med; 2000 Sep; 343(13):963-4. PubMed ID: 11006373
[No Abstract] [Full Text] [Related]
8. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
Erlichman C; Goldberg RM; O'Connell MJ
N Engl J Med; 2001 Jan; 344(4):305; author reply 306-7. PubMed ID: 11191661
[No Abstract] [Full Text] [Related]
9. Irinotecan/5-FU/leucovorin, oxaliplatin/5-FU/leucovorin, and oxaliplatin/irinotecan are each effective in the treatment of 5-FU-resistant advanced colorectal cancer.
Fisher MD
Clin Colorectal Cancer; 2001 Aug; 1(2):85-6. PubMed ID: 12445365
[No Abstract] [Full Text] [Related]
10. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
Goldberg RM; Sargent DJ; Morton RF; Fuchs CS; Ramanathan RK; Williamson SK; Findlay BP; Pitot HC; Alberts S
J Clin Oncol; 2006 Jul; 24(21):3347-53. PubMed ID: 16849748
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer.
Douillard JY;
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):51-5. PubMed ID: 11200150
[TBL] [Abstract][Full Text] [Related]
12. Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer.
Saltz L
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):47-50. PubMed ID: 11200149
[TBL] [Abstract][Full Text] [Related]
13. Regional administration of irinotecan in combination with 5-fluorouracil and leucovorin in patients with colorectal cancer liver metastases--a pilot experience.
Melichar B; Dvorák J; Jandík P; Tousková M; Malírová E; Megancová J; Voboril Z
Hepatogastroenterology; 2001; 48(42):1721-6. PubMed ID: 11813608
[TBL] [Abstract][Full Text] [Related]
14. Considering Efficacy and Cost, Where Does Ramucirumab Fit in the Management of Metastatic Colorectal Cancer?
Goldstein DA; El-Rayes BF
Oncologist; 2015 Sep; 20(9):981-2. PubMed ID: 26265225
[TBL] [Abstract][Full Text] [Related]
15. Mayo regimen plus three different second-line chemotherapy regimens in sequential therapy in patients with advanced colorectal cancer (ACRC).
Popov IP; Jelic SB; Matijasevic MM; Grbic B; Babic DR
J Exp Clin Cancer Res; 2004 Sep; 23(3):395-401. PubMed ID: 15595627
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.
Chang DZ; Abbruzzese JL
Clin Adv Hematol Oncol; 2005 May; 3(5):400-4. PubMed ID: 16167013
[No Abstract] [Full Text] [Related]
17. Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer.
Cunningham D; Falk S; Jackson D
Br J Cancer; 2002 Jun; 86(11):1677-83. PubMed ID: 12087449
[TBL] [Abstract][Full Text] [Related]
18. [Four cases of advanced colorectal cancer successfully treated with irinotecan plus 5-fluorouracil and l-leucovorin combination chemotherapy].
Kamoshita N; Makita F; Aiba M; Tokiniwa H; Nagashima T; Takeyoshi I; Ohwada S; Morishita Y
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1187-90. PubMed ID: 16121927
[TBL] [Abstract][Full Text] [Related]
19. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
Allegra C; George T; Yothers G
J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
[No Abstract] [Full Text] [Related]
20. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
Motomura S
Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
